Comparative Analysis of Mesenchymal Stem Cells from Bone Marrow, Umbilical Cord Blood, or Adipose Tissue
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Mesenchymal stem cells (MSCs) represent a promising tool for new clinical concepts in supporting cellular therapy. Bone marrow (BM) was the first source reported to contain MSCs. However, for clinical use, BM may be detrimental due to the highly invasive donation procedure and the decline in MSC number and differentiation potential with increasing age. More recently, umbilical cord blood (UCB), attainable by a less invasive method, was introduced as an alternative source for MSCs. Another promising source is adipose tissue (AT). We compared MSCs derived from these sources regarding morphology, the success rate of isolating MSCs, colony frequency, expansion potential, multiple differentiation capacity, and immune phenotype. No significant differences concerning the morphology and immune phenotype of the MSCs derived from these sources were obvious. Differences could be observed concerning the success rate of isolating MSCs, which was 100% for BM and AT, but only 63% for UCB. The colony frequency was lowest in UCB, whereas it was highest in AT. However, UCB-MSCs could be cultured longest and showed the highest proliferation capacity, whereas BM-MSCs possessed the shortest culture period and the lowest proliferation capacity. Most strikingly, UCB-MSCs showed no adipogenic differentiation capacity, in contrast to BM- and AT-MSCs. Both UCB and AT are attractive alternatives to BM in isolating MSC: AT as it contains MSCs at the highest frequency and UCB as it seems to be expandable to higher numbers.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As plating density can affect proliferation kinetics of MSCs [16, 23], cells from all tissue sources were grown for at least two passages under two seeding densities: 300 and 3000 cells/cm2.”
Citations
Cites
Multilineage potential of adult human mesenchymal stem cells
Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., & Marshak, D. R. (1999) · Science · doi:10.1126/science.284.5411.143 · Cited by 21,052
Human Adipose Tissue Is a Source of Multipotent Stem Cells
Zuk, P. A., Zhu, M., Ashjian, P., De Ugarte, D. A., Huang, J. I., Mizuno, H., Alfonso, Z. C., Fraser, J. K., Benhaim, P., & Hedrick, M. H. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-02-0105 · Cited by 6,664
Caplan, A. I. (1991) · Journal of Orthopaedic Research · doi:10.1002/jor.1100090504 · Cited by 6,548
Le Blanc, K., Rasmusson, I., Sundberg, B., Götherström, C., Hassan, M., Uzunel, M., & Ringdén, O. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16104-7 · Cited by 2,734
Horwitz, E. M., Gordon, P. L., Koo, W. K. K., Marx, J. C., Neel, M. D., McNall, R. Y., Muul, L., & Hofmann, T. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.132252399 · Cited by 1,650
Mesenchymal progenitor cells in human umbilical cord blood
Erices, A., Conget, P., & Minguell, J. J. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.01986.x · Cited by 1,613
Isolation of multipotent mesenchymal stem cells from umbilical cord blood
Lee, O. K., Kuo, T. K., Chen, W.-M., Lee, K.-D., Hsieh, S.-L., & Chen, T.-H. (2004) · Blood · doi:10.1182/blood-2003-05-1670 · Cited by 1,360
Wagner, W., Wein, F., Seckinger, A., Frankhauser, M., Wirkner, U., Krause, U., Blake, J., Schwager, C., Eckstein, V., Ansorge, W., et al. (2005) · Experimental Hematology · doi:10.1016/j.exphem.2005.07.003 · Cited by 1,259
Stenderup, K. (2003) · Bone · doi:10.1016/j.bone.2003.07.005 · Cited by 1,206
Kögler, G., Sensken, S., Airey, J. A., Trapp, T., Müschen, M., Feldhahn, N., Liedtke, S., Sorg, R. V., Fischer, J., Rosenbaum, C., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040440 · Cited by 1,029
Research works printed but not linked: 1
- 10.1210/endo.134.1.8275945 · doi:10.1210/endo.134.1.8275945 · Paper page
Cited by
Items 301–400 of 1,013
Hypoxia enhances proliferation and stemness of human adipose-derived mesenchymal stem cells
Fotia, C., Massa, A., Boriani, F., Baldini, N., & Granchi, D. (2014) · Cytotechnology · doi:10.1007/s10616-014-9731-2 · Cited by 146
Immunological Applications of Stem Cells in Type 1 Diabetes
Fiorina, P., Voltarelli, J., & Zavazava, N. (2011) · Endocrine Reviews · doi:10.1210/er.2011-0008 · Cited by 135
“MSCs are multipotent cells localized in several tissues including CB, bone marrow, and adipose tissue (113); however, we will primarily refer to the cell derived from the most widely used source: the bone marrow-derived MSCs.”
BackgroundAltaner, Č. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.04.023 · Cited by 138
A Comprehensive Review on Mesenchymal Stem Cell Growth and Senescence
Książek, K. (2009) · Rejuvenation Research · doi:10.1089/rej.2009.0830 · Cited by 131
“40 This effect is of special importance given that the cell isolation efficacy of the former was appreciably lower.”
InfluentialLü, J., Shen, X., Sun, X., Yin, H., Yang, S., Lu, C., Wang, Y., Liu, Y., Huang, Y., Yang, Z., et al. (2018) · Theranostics · doi:10.7150/thno.26981 · Cited by 142
Billing, A. M., Ben Hamidane, H., Dib, S. S., Cotton, R. J., Bhagwat, A. M., Kumar, P., Hayat, S., Yousri, N. A., Goswami, N., Suhre, K., et al. (2016) · Scientific Reports · doi:10.1038/srep21507 · Cited by 134
Adipose Tissue-Derived Mesenchymal Stem Cells Facilitate Hematopoiesis in Vitro and in Vivo
Nakao, N., Nakayama, T., Yahata, T., Muguruma, Y., Saito, S., Miyata, Y., Yamamoto, K., & Naoe, T. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.091042 · Cited by 143
Mesenchymal stromal cells from human perinatal tissues: From biology to cell therapy
Sancricca, C. (2010) · World Journal of Stem Cells · doi:10.4252/wjsc.v2.i4.81 · Cited by 138
Biological characteristics of human menstrual blood‐derived endometrial stem cells
Liu, Y., Niu, R., Yang, F., Yan, Y., Liang, S., Sun, Y., Shen, P., & Lin, J. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13437 · Cited by 137
YAP as a key regulator of adipo-osteogenic differentiation in human MSCs
Lorthongpanich, C., Thumanu, K., Tangkiettrakul, K., Jiamvoraphong, N., Laowtammathron, C., Damkham, N., U‐pratya, Y., & Issaragrisil, S. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1494-4 · Cited by 143
Recent Strategies and Advances in Hydrogel-Based Delivery Platforms for Bone Regeneration
Wang, X., Zeng, J., Gan, D., Ling, K., He, M., Li, J., & Lu, Y. (2024) · Nano-Micro Letters · doi:10.1007/s40820-024-01557-4 · Cited by 156
Wu, L., Wang, N.-N., Liu, Y., & Wei, X. (2009) · Tissue Engineering Part A · doi:10.1089/ten.tea.2008.0579 · Cited by 143
“16 Bone marrow was layered over a lymphoprep gradient and centrifuged at 2000rpm for 15min.”
Extracellular calcium and CaSR drive osteoinduction in mesenchymal stromal cells
González‐Vázquez, A., Planell, J. A., & Engel, E. (2014) · Acta Biomaterialia · doi:10.1016/j.actbio.2014.02.004 · Cited by 135
In vitro Differentiation Potential of Mesenchymal Stem Cells
Gimble, J. M., Guilak, F., NUTTALL, M. E., Sathishkumar, S., Vidal, M. A., & Bunnell, B. A. (2008) · Transfusion Medicine and Hemotherapy · doi:10.1159/000124281 · Cited by 156
Koch, T. G., Berg, L. C., & Betts, D. H. (2009) · Research at the University of Copenhagen (University of Copenhagen) · Cited by 167
Mesenchymal-stem-cell-based experimental and clinical trials: current status and open questions
Wang, J., Liao, L., & Tan, J. (2011) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2011.574119 · Cited by 131
“Compared with adult bone-marrow-derived MSCs, fetal MSCs can be cultured for a longer time with a high proliferation capacity [154,155].”
BackgroundTissue Engineered Skin Substitutes
Goodarzi, P., Falahzadeh, K., Nematizadeh, M., Farazandeh, P., Payab, M., Larijani, B. A., Tayanloo-Beik, A., & Arjmand, B. (2018) · Advances in experimental medicine and biology · doi:10.1007/5584_2018_226 · Cited by 142
Lin, H., Liou, C., Chen, S., Hsu, T., Chuang, J., Wang, P., Huang, S., Tiao, M., Chen, J., Lin, T., et al. (2015) · Mitochondrion · doi:10.1016/j.mito.2015.02.006 · Cited by 135
Purinergic Receptors Influence the Differentiation of Human Mesenchymal Stem Cells
Zippel, N., Limbach, C. A., Ratajski, N., Urban, C., Luparello, C., Pansky, A., Kassack, M. U., & Tobiasch, E. (2011) · Stem Cells and Development · doi:10.1089/scd.2010.0576 · Cited by 132
Comparison of human mesenchymal stem cells derived from adipose and cord tissue
Choudhery, M. S., Badowski, M., Muise, A., & Harris, D. T. (2013) · Cytotherapy · doi:10.1016/j.jcyt.2012.11.010 · Cited by 142
Prather, W. R., Toren, A., Meiron, M., Ofir, R., Tschöpe, C., & Horwitz, E. M. (2009) · Cytotherapy · doi:10.1080/14653240902849762 · Cited by 132
Mesenchymal Stem Cell Exosome Ameliorates Reperfusion Injury Through Proteomic Complementation
Lai, R. C., Yeo, R. W. Y., Tan, K. H., & Lim, S. K. (2013) · Regenerative Medicine · doi:10.2217/rme.13.4 · Cited by 129
Mesenchymal stem cells as all-round supporters in a normal and neoplastic microenvironment
Hass, R., & Otte, A. (2012) · Cell Communication and Signaling · doi:10.1186/1478-811x-10-26 · Cited by 141
“According to the tissue-specific microenvironment of the diverse MSC populations, UC-MSC exhibit a higher proliferation potential than BM-MSC [17-19].”
InfluentialOsteoporosis: the current status of mesenchymal stem cell-based therapy
Phetfong, J., Sanvoranart, T., Nartprayut, K., Nimsanor, N., Seenprachawong, K., Prachayasittikul, V., & Supokawej, A. (2016) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-016-0013-1 · Cited by 136
“Sanvoranart et al. demonstrated that PL-MSCs responded to bortezomib, a chemo- therapeutic agent that improves osteolytic lesions in multiple myeloma, via enhance- ment of osteogenic differentiation, similarly to BM-MSCs [140].”
InfluentialCartilage tissue formation through assembly of microgels containing mesenchymal stem cells
Li, F., Truong, V. X., Fisch, P., Levinson, C., Glattauer, V., Zenobi‐Wong, M., Thissen, H. W., Forsythe, J. S., & Frith, J. E. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.07.015 · Cited by 136
Burk, J., Ribitsch, I., Gittel, C., Jülke, H., Kasper, C., Staszyk, C., & Brehm, W. (2012) · The Veterinary Journal · doi:10.1016/j.tvjl.2012.06.004 · Cited by 131
Human mesenchymal stem cells and their use in cell‐based therapies
Motaln, H., Schichor, C., & Lah, T. T. (2010) · Cancer · doi:10.1002/cncr.25056 · Cited by 129
“With 100% efficiency they can be isolated from bone marrow (BM) aspirates, adipose tissues, and umbilical cords,(5) whereas from fresh cord blood the isolation efficiency is only 30%(5) to 63%.(6,7) The lowest 19.”
BackgroundEckert, M. A., Vu, Q., Xie, K., Yu, J., Liao, W., Cramer, S. C., & Zhao, W. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.91 · Cited by 146
Chang, Y. S., Choi, S. J., Sung, D. K., Kim, S. Y., Oh, W., Yang, Y. S., & Park, W. S. (2011) · Cell Transplantation · doi:10.3727/096368911x565038a · Cited by 137
Kang, R., Zhou, Y., Tan, S., Zhou, G., Aagaard, L., Xie, L., Bünger, C. E., Bolund, L., & Luo, Y. (2015) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0137-7 · Cited by 137
“Although MSCs can be easily isolated from various sources of adult tissues, such as BM, fat, placenta, blood, spleen, heart, pancreas, joints and so forth [34–36], this repetitive MSC isolation procedure would cause pain and risk of infection for patients.”
BackgroundTeven, C. M., Liu, X., Hu, N., Tang, N., Kim, S. H., Huang, E., Yang, K., Li, M., Gao, J., Liu, H., et al. (2011) · Stem Cells International · doi:10.4061/2011/201371 · Cited by 145
“For example, MSCs derived from adipose tissue (adipocyte-derived stem cells; ASCs), as well as MSCs derived from bone marrow (bone marrow MSCs; BMMSCs), express similar gene expression profiles [99–101], surface markers [94, 98], and share a similar differentiation potential [98, 102].”
BackgroundStem cell mechanobiology: diverse lessons from bone marrow
Ivanovska, I. L., Shin, J., Swift, J., & Discher, D. E. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2015.04.003 · Cited by 135
In vitro analysis of mesenchymal stem cells derived from human teeth and bone marrow
Tamaki, Y., Nakahara, T., Ishikawa, H., & Sato, S. (2012) · Odontology · doi:10.1007/s10266-012-0075-0 · Cited by 141
Adult stem cell-based tissue engineered blood vessels: A review
Krawiec, J. T., & Vorp, D. A. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.01.014 · Cited by 144
“marrow, and adipose [42,43], adipose MSCs could be harvested in the largest frequency with approximately 557 per 1 106 stromal vascular cells, compared to bonemarrowMSCs with approximately 81 per 1 106 mononuclear cells and umbilical cord MSCs with approximately 0.”
BackgroundDavies, O. G., Cooper, P. R., Shelton, R. M., Smith, A. J., & Scheven, B. A. A. (2014) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-014-0601-y · Cited by 144
Immunological properties of umbilical cord blood-derived mesenchymal stromal cells
Oh, W., Kim, D., Yang, Y. S., & Lee, J. K. (2008) · Cellular Immunology · doi:10.1016/j.cellimm.2008.04.003 · Cited by 137
Tissue-Engineering Strategies for the Tendon/Ligament-to-Bone Insertion
Smith, L. J., Younan Xia, A., Galatz, L. M., Genin, G. M., & Thomopoulos, S. (2011) · Connective Tissue Research · doi:10.3109/03008207.2011.650804 · Cited by 129
Moreno-Jiménez, I., Hulsart‐Billström, G., Lanham, S., Janeczek, A. A., Kontouli, N., Kanczler, J. M., Evans, N. D., & Oreffo, R. O. C. (2016) · Scientific Reports · doi:10.1038/srep32168 · Cited by 129
Clinical utility of mesenchymal stem/stromal cells in regenerative medicine and cellular therapy
Maldonado, V. V., Patel, N. H., Smith, E. E., Barnes, C. L., Gustafson, M. P., Rao, R. R., & Samsonraj, R. M. (2023) · Journal of Biological Engineering · doi:10.1186/s13036-023-00361-9 · Cited by 138
“Nevertheless, UCB-MSCs can be cultured for a longer time and have a higher capacity to proliferate compared to BM-MSCs [13].”
BackgroundTwo steps to functional mesenchymal stromal cells for clinical application
Bartmann, C., Rohde, E., Schallmoser, K., Pürstner, P., Lanzer, G., Linkesch, W., & Strunk, D. (2007) · Transfusion · doi:10.1111/j.1537-2995.2007.01219.x · Cited by 137
DNA methylation in stem cell renewal and multipotency
Berdasco, M., & Esteller, M. (2011) · Stem Cell Research & Therapy · doi:10.1186/scrt83 · Cited by 144
“Multipotent cells isolated from diff erent tissues have common in vitro phenotypic and functional characteristics (for example, MSCs share fi broblast-like morphology, plastic adherence, proliferation ability, and clonogenicity) but diff er in the expression of specifi c lineage markers (for example, ASCs and BM-MSCs…”
BackgroundPark, W. S., Sung, S. I., Ahn, S. Y., Yoo, H. S., Sung, D. K., Im, G. H., Choi, S. J., & Chang, Y. S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120893 · Cited by 126
Dong, Y., Hassan, W. U., Kennedy, R., Greiser, U., Pandit, A. S., García, Y., & Wang, W. (2014) · Acta Biomaterialia · doi:10.1016/j.actbio.2013.12.045 · Cited by 126
Journey into Bone Models: A Review
Scheinpflug, J., Pfeiffenberger, M., Damerau, A., Schwarz, F., Textor, M., Lang, A., & Schulze, F. (2018) · Genes · doi:10.3390/genes9050247 · Cited by 137
“Since the availability of human BM-MSCs is limited as a result of a very painful retrieval procedure or the reliance on bone marrow that is discarded in the course of orthopaedic surgeries, other isolation sources from a variety of tissues, such as adipose tissue [42], umbilical cord blood [32,35,36,43], peripheral bl…”
BackgroundMethodStem Cells for Bronchopulmonary Dysplasia in Preterm Infants: A Randomized Controlled Phase II Trial
Ahn, S. Y., Chang, Y. S., Lee, M. H., Sung, S. I., Lee, B. S., Kim, K. S., Kim, A.-R., & Park, W. S. (2021) · Stem Cells Translational Medicine · doi:10.1002/sctm.20-0330 · Cited by 126
The therapeutic potential of mesenchymal stem cells: Cell- & Tissue-based Therapy
Picinich, S. C., Mishra, P. J., Mishra, P. J., Glod, J., & Banerjee, D. (2007) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.7.7.965 · Cited by 123
Yoon, J. H., Roh, E. Y., Shin, S., Jung, N. H., Song, E. Y., Chang, J. Y., Kim, B. J., & Jeon, H. W. (2013) · BioMed Research International · doi:10.1155/2013/428726 · Cited by 132
“Hindawi Publishing Corporation BioMed Research International Volume 2013, Article ID 428726, 8 pages http://dx.doi.org/10.1155/2013/428726”
InfluentialIsolation and characterization of canine umbilical cord blood-derived mesenchymal stem cells
Seo, M.-S., Jeong, Y.-H., Park, J.-R., Park, S., Rho, K.-H., Kim, H.-S., Yu, K., Lee, S. H., Jung, J.-W., Lee, Y.-S., et al. (2009) · Journal of Veterinary Science · doi:10.4142/jvs.2009.10.3.181 · Cited by 137
“A similarity between various tissues has been observed in previous studies [20,21].”
ResultDo mesenchymal stem cells function across species barriers? Relevance for xenotransplantation
Li, J., Ezzelarab, M. B., & Cooper, D. K. C. (2012) · Xenotransplantation · doi:10.1111/xen.12000 · Cited by 134
Hilfiker, A., Kasper, C., Hass, R., & Haverich, A. (2011) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-011-0762-2 · Cited by 137
“Based on these reviews, the most common sources for this purpose are bone marrow (BM) and adipose tissue [53, 56, 62–64].”
Schäfer, R., Spohn, G., & Baer, P. C. (2016) · Transfusion Medicine and Hemotherapy · doi:10.1159/000447458 · Cited by 120
Multiplicity of Mesenchymal Stromal Cells: Finding the Right Route to Therapy
Wilson, A., Hodgson-Garms, M., Frith, J. E., & Genever, P. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01112 · Cited by 124
Strategies for scalable manufacturing and translation of MSC-derived extracellular vesicles
Adlerz, K. M., Patel, D. B., Rowley, J. A., Ng, K. S., & Ahsan, T. (2020) · Stem Cell Research · doi:10.1016/j.scr.2020.101978 · Cited by 128
Jin, H. J., Park, S. K., Oh, W., Yang, Y. S., Kim, S. W., & Choi, S. J. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.02.118 · Cited by 135
Lee, S. Y., Choi, S. Y., Song, M. S., Ryu, P. D., Joo, S., & Lam, A. T. N. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s78775 · Cited by 123
Engineering a humanized bone organ model in mice to study bone metastases
Martine, L. C., Holzapfel, B. M., McGovern, J., Wagner, F., Quent, V. M. C., Hesami, P., Wunner, F. M., Vaquette, C., De‐Juan‐Pardo, E. M., Brown, T. D., et al. (2017) · Nature Protocols · doi:10.1038/nprot.2017.002 · Cited by 130
Song, W., Li, Q., Ryu, M., Ahn, J., Bhang, D. H., Jung, Y. C., & Youn, H. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-0841-1 · Cited by 134
Mesenchymal stem cells in preclinical cancer cytotherapy: a systematic review
Christodoulou, I., Goulielmaki, M., Devetzi, M., Panagiotidis, M., Koliakos, G., & Zoumpourlis, V. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-1078-8 · Cited by 122
“Ιndeed, BM-MSC have the least favorable characteristics in terms of tissue accessibility/abundance for harvesting purposes since their isolation relies on invasive, painful techniques that use aspiration needles to reach their anatomical source (usually the marrow cavity of the pelvic bones) and which are often associ…”
BackgroundThe role and potential of umbilical cord blood in an era of new therapies: a review
Roura, S., Pujal, J. M., Gálvez‐Montón, C., & Bayés‐Genís, A. (2015) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0113-2 · Cited by 122
“In general, these ‘stem’ or progenitor cells belong to hematopoietic or non-hematopoietic lineages and show higher in vitro proliferative ability than those from additional body sources such as bone marrow and adipose tissue [49, 50].”
BackgroundFernandes, T. J., Hodge, J. M., Singh, P. P., Eeles, D. G., Collier, F. M., Holten, I., Ebeling, P. R., Nicholson, G. C., & Quinn, J. M. W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073266 · Cited by 121
Mesenchymal stem cells and cardiac repair
Nesselmann, C., Ma, N., Bieback, K., Wagner, W., Ho, A., Konttinen, Y. T., Zhang, H., Hinescu, M. E., & Steinhoff, G. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00457.x · Cited by 119
Self-citationSivaraman, D. M., Roshin, G. E., Divya, T. S., Rasheed, V. A., Santhoshkumar, T. R., Elizabeth, K. E., James, J., & Pillai, R. M. (2012) · Stem Cell Research & Therapy · doi:10.1186/scrt148 · Cited by 127
Use of Adipose Tissue-Derived Mesenchymal Stem Cells for Experimental Tendinitis Therapy in Equines
Carvalho, A. D. M., Alves, A. L. G., Oliveira, P. G. G., Álvarez, L. E. C., Amorim, R. L., Hussni, C. A., & Deffune, E. (2011) · Journal of Equine Veterinary Science · doi:10.1016/j.jevs.2010.11.014 · Cited by 122
“In this experiment, the immunophenotypic characterization of the surface of the MSCs used was conducted with the markers CD13, CD44, and CD90.”
ResultInfluentialColleoni, S., Bottani, E., Tessaro, I. A., Mari, G., Merlo, B., Romagnoli, N., Spadari, A., Galli, C., & Lazzari, G. (2009) · Veterinary Research Communications · doi:10.1007/s11259-009-9229-0 · Cited by 136
“Similar finding have been previously described (Izadpanah et al. 2006; Kern et al. 2006; Lee et al. 2004) although other authors did not find any significant differences among MSC from different sources (De Ugarte et al.”
The Effect of Age on Human Adipose-Derived Stem Cells
Wu, W., Niklason, L. E., & Steinbacher, D. M. (2012) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0b013e3182729cfc · Cited by 128
Krawczenko, A., & Klimczak, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052425 · Cited by 128
“Human AT-MSCs have a basic MSC phenotype expressing CD73, CD90, and CD105 as well as HLA ABC markers with a concomitant lack of expression of CD34, CD45, CD14, and HLA DR [3,8].”
BackgroundAn, C., Yang, C., Yuan, Q., & Li, J. (2010) · Annals of Biomedical Engineering · doi:10.1007/s10439-009-9892-x · Cited by 122
Adipose-derived stem cells seeded in Pluronic F-127 hydrogel promotes diabetic wound healing
Kaisang, L., Wang, S., Fan, L.-J., Daoyan, P., Xian, C. J., & Shen, J. (2017) · Journal of Surgical Research · doi:10.1016/j.jss.2017.04.032 · Cited by 120
“They are abundant in the adipose tissue, which are easy to access and can be collected in a minimally invasive way [34].”
BackgroundNeuron-like Differentiation of Adipose-Derived Stem Cells From Infant Piglets in Vitro
Huang, T., He, D., Kleiner, G., & Kuluz, J. W. (2007) · Journal of Spinal Cord Medicine · doi:10.1080/10790268.2007.11753967 · Cited by 120
Mesenchymal Stem Cells: Characteristics, Sources, and Mechanisms of Action
Stewart, M. C., & Stewart, A. A. (2011) · Veterinary Clinics of North America Equine Practice · doi:10.1016/j.cveq.2011.06.004 · Cited by 147
The generation of hepatocytes from mesenchymal stem cells and engraftment into murine liver
Stock, P., Brückner, S., Ebensing, S., Hempel, M., Dollinger, M. M., & Christ, B. (2010) · Nature Protocols · doi:10.1038/nprot.2010.7 · Cited by 125
“, adipogenic over osteogenic differentiation of adipose tissue-derived MSCs and osteogenic over adipogenic differentiation of bone marrow-derived MSCs (unpublished observation and see refs”
BackgroundYoo, S.-W., Chang, D.-Y., Lee, H.-S., Kim, G.-H., Park, J.-S., Ryu, B.-Y., Joe, E.-H., Lee, Y.-D., Kim, S.-S., & Suh-Kim, H. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.06.001 · Cited by 120
Iacono, E., Brunori, L., Pirrone, A., Pagliaro, P., Ricci, F., Tazzari, P. L., & Merlo, B. (2012) · Reproduction · doi:10.1530/rep-10-0408 · Cited by 132
“On the other hand, data reported for human UCB (Kern et al. 2006) are lower than that of ours.”
ResultZhang, Y., Xing, Y., Jia, L., Ji, Y., Zhao, B., Wen, Y., & Xu, X. (2018) · Stem Cells and Development · doi:10.1089/scd.2018.0119 · Cited by 123
“Previous studies compared MSCs isolated from bone marrow, adipose tissue, and umbilical cord and found that BM-MSCs had the lowest proliferative capacity, while umbilical cord-derived MSCs showed the highest proliferation potency [29,30].”
Current Trends and Future Perspective of Mesenchymal Stem Cells and Exosomes in Corneal Diseases
Mansoor, H., Ong, H. S., Riau, A. K., Stanzel, T. P., Mehta, J. S., & Yam, G. H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20122853 · Cited by 126
“Early senescence of bone marrow MSCs was also detected while adipose MSCs displayed the associated signs at later passages [32].”
BackgroundChristodoulou, I., Kolisis, F. N., Papaevangeliou, D., & Zoumpourlis, V. (2013) · Stem Cells International · doi:10.1155/2013/246134 · Cited by 109
Pelekanos, R., Li, J., Gongora, M., Chandrakanthan, V., Scown, J., Suhaimi, N., Brooke, G. P., Christensen, M. E., Doan, T. B., Rice, A. M., et al. (2011) · Stem Cell Research · doi:10.1016/j.scr.2011.08.003 · Cited by 131
Targeting Rat Brainstem Glioma Using Human Neural Stem Cells and Human Mesenchymal Stem Cells
Lee, D., Ahn, Y., Kim, S. U., Wang, K., Cho, B.-K., Phi, J. H., Park, I. H., Black, P. M., Carroll, R. S., Lee, J., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-3076 · Cited by 120
“Recently, umbilical cord blood has been used as an alternative source of MSCs (34).”
BackgroundПавличенко, Н. Н., Sokolova, I. B., Sv, V., Shvedova, E. V., Alexandrov, G., Krouglyakov, P., Fedotova, O. R., Gilerovich, E. G., Полынцев, Д. Г., & Otellin, V. A. (2008) · Brain Research · doi:10.1016/j.brainres.2008.06.123 · Cited by 118
“Reproducible methods of obtaining and cultivating of highly purified MSC populations in vitro have been developed (Ahrens et al., 2004; Baksh et al., 2004; Barry, 2003; Beyer Nardi and da Silva Meirelles, 2006; Delorme and Charbord, 2007; Deschaseaux et al., 2003; Jones and McGonagle, 2007; Kassem, 2004; Kemp et al.,…”
Montesinos, J. J., Figueroa, E. F., Castillo-Medina, S., Flores-Guzmán, P., Hernández-Estévez, É., Fajardo-Orduña, G. R., Orozco, S., & Mayani, H. (2009) · Cytotherapy · doi:10.1080/14653240802582075 · Cited by 125
Zhang, Y., Lie, P., & Wei, X. (2009) · Cytotherapy · doi:10.1080/14653240903051533 · Cited by 125
Current perspectives in stem cell research for knee cartilage repair
Orth, P., Rey‐Rico, A., Venkatesan, J. K., Madry, H., & Cucchiarini, M. (2014) · Stem Cells and Cloning Advances and Applications · doi:10.2147/sccaa.s42880 · Cited by 135
The clinical application of mesenchymal stromal cells in hematopoietic stem cell transplantation
Zhao, K., & Liu, Q. (2016) · Journal of Hematology & Oncology · doi:10.1186/s13045-016-0276-z · Cited by 126
“Nowadays, MSCs products are derived from different tissue (BM, AT, UCB, or placental), different donors (autologous, donor derived, or third-party), different laboratories (industrial or manufactured by academic centers), and are cultured and expanded from different media and conditions [4, 5, 84, 104].”
BackgroundPark, W. S., Ahn, S. Y., Sung, S. I., Ahn, J., & Chang, Y. S. (2017) · Pediatric Research · doi:10.1038/pr.2017.249 · Cited by 122
“MSCs obtained from gestational tissues such as UCB (105), Wharton’s jelly, or umbilical cords (106) showed increased secretion of chemokines, proinflammatory proteins, and growth factors, as well as higher rate of cell proliferation, than MSCs obtained from adult adipose tissue or bone marrow.”
BackgroundInfluentialHigh-throughput fabrication of vascularized spheroids for bioprinting
Moor, L. D., Merovci, I., Baetens, S., Verstraeten, J., Kowalska, P., Krysko, D. V., Vos, W. H. D., & Declercq, H. (2018) · Biofabrication · doi:10.1088/1758-5090/aac7e6 · Cited by 121
“harvested from patient-derived material[45].”
Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients
Rogers, C. J., Harman, R. J., Bunnell, B. A., Schreiber, M. A., Xiang, C. C., Wang, F., Santidrián, A. F., & Minev, B. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02380-2 · Cited by 120
Lim, H.-C., Park, Y., Ha, C., Cole, B. J., Lee, B.-K., Jeong, H. J., Kim, M. K., Bin, S., Choi, C., Choi, C. H., et al. (2021) · Orthopaedic Journal of Sports Medicine · doi:10.1177/2325967120973052 · Cited by 120
“Umbilical cord blood–derived MSCs (UCB-MSCs) have advantages over other MSCs, including noninvasive cell collection, hypoimmunogenicity, and high expansion capacity.(8,19) Moreover, allogeneic MSC implantation has the advantages of 1-step surgery and better quality control of the cells compared with a 2-step procedure…”
BackgroundTreatment of diabetic wounds with fetal murine mesenchymal stromal cells enhances wound closure
Badillo, A. T., Redden, R. A., Zhang, L., Doolin, E. J., & Liechty, K. W. (2007) · Cell and Tissue Research · doi:10.1007/s00441-007-0417-3 · Cited by 116
“However, the only differences in differentiation properties have been seen in MSC isolated from adult spleen, umbilical cord blood, and adult liver (in ’t Anker et al. 2003; Kern et al. 2006).”
BackgroundVerseijden, F., Sluijs, S. J. P.-V., Pavljasevic, P., Hofer, S. O. P., van Osch, G. J. V. M., & Farrell, E. (2009) · Tissue Engineering Part A · doi:10.1089/ten.tea.2009.0106 · Cited by 128
“26 The idea that not only BMSCs but also ASCs could support the formation of pre-vascular-like structures in an in vitro tissue-engineering context is therefore very attractive.”
Human Mesenchymal Stem Cells Display Reduced Expression of CD105 after Culture in Serum-Free Medium
Mark, P., Kleinsorge, M., Gaebel, R., Lux, C. A., Toelk, A., Pittermann, E., David, R., Steinhoff, G., & Ma, N. (2013) · Stem Cells International · doi:10.1155/2013/698076 · Cited by 127
Preparation of cardiac extracellular matrix scaffolds by decellularization of human myocardium
Oberwallner, B., Brodarac, A., Choi, Y.-H., Saric, T., Anić, P., Morawietz, L., & Stamm, C. (2013) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbma.35000 · Cited by 89
Avanzini, M. A., Bernardo, M. E., Cometa, A. M., Perotti, C. G., Zaffaroni, N., Novara, F., Visai, L., Moretta, A., Fante, C. D., Villa, R., et al. (2009) · Haematologica · doi:10.3324/haematol.2009.006171 · Cited by 122
Mesenchymal stem cells: from biology to clinical use.
Krampera, M., Franchini, M., Pizzolo, G., & Aprili, G. (2007) · PubMed · doi:10.2450/2007.0029-07 · Cited by 135
Bader, A. M., Klose, K., Bieback, K., Korinth, D., Schneider, M., Seifert, M., Choi, Y.-H., Kurtz, A., Falk, V., & Stamm, C. (2015) · PLOS ONE · doi:10.1371/journal.pone.0138477 · Cited by 111
Self-citationThe Impact of Simulated and Real Microgravity on Bone Cells and Mesenchymal Stem Cells
Ulbrich, C., Wehland, M., Pietsch, J., Aleshcheva, G., Wise, P. M., van Loon, J. J. W. A., Magnusson, N. E., Infanger, M., Grosse, J., Eilles, C., et al. (2014) · BioMed Research International · doi:10.1155/2014/928507 · Cited by 122
“The first important factor is the cell type. a proliferating and undifferentiated cell source, but their availability is limited [147, 148].”
Nazempour, A., & Wie, B. V. (2016) · Annals of Biomedical Engineering · doi:10.1007/s10439-016-1575-9 · Cited by 121
Fang, J., Zhao, X., Li, S., Xing, X., Wang, H., Lazarovici, P., & Zheng, W. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1419-2 · Cited by 118
“007% of cell population expressed this marker) [53, 54].”
BackgroundWang, J., Geesman, G. J., Hostikka, S. L., Atallah, M., Blackwell, B., Lee, E., Cook, P. J., Pasaniuc, B., Shariat, G., Halperin, E., et al. (2011) · Cell Cycle · doi:10.4161/cc.10.17.17543 · Cited by 109
Yang, X.-F., He, X., He, J., Zhang, L.-H., Su, X.-J., Dong, Z.-Y., Xu, Y.-J., Li, Y., & Li, Y.-L. (2011) · Journal of Biomedical Science · doi:10.1186/1423-0127-18-59 · Cited by 112
Carvalho, M. M., Teixeira, F. G., Reis, R. L., Sousa, N., & Salgado, A. J. (2011) · Current Stem Cell Research & Therapy · doi:10.2174/157488811796575332 · Cited by 120
“Inconsistencies in culture protocols can help explain such variation, but interestingly even when cultured under the same conditions, some MSC populations were shown to have limited capacity to derivate into certain cell types [28-31].”
Background
Metadata
- Authors
- Kern, S., Eichler, H., Stoeve, J., Klüter, H., & Bieback, K.
- Affiliations
- German Red Cross (DE)
- Department of Orthopaedic Surgery of the University Hospital Mannheim, University of Heidelberg, Faculty of Clinical Medicine, Mannheim, Germany
- Corresponding author
- Bieback, Karen
- Venue
- STEM CELLS
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-05
- Volume
- 24
- Issue
- 5
- Pages
- 1294-1301
- ISSN
- 1066-5099 (ISSN-L)
- 1549-4918
- OpenAlex
- W2036348189
- Cited by
- 3,370
- References
- 37
- Citations by year
- 2026: 57 · 2025: 97 · 2024: 142 · 2023: 136 · 2022: 176 · 2021: 201 · 2020: 225 · 2019: 197 · 2018: 190 · 2017: 193 · 2016: 208 · 2015: 218 · 2014: 225 · 2013: 242 · 2012: 213
- FWCI
- 49.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- onlinelibrary.wiley.com/termsAndConditions#vor (vor)
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm)
- Locations
- Stem Cells (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Keywords
- mesenchymal stem cells, bone marrow, umbilical cord blood, adipose tissue, stem cell isolation, adipogenesis, multilineage differentiation, immunophenotype, stem cell expansion, cell therapy
- MeSH terms
- Adipose Tissue, Aged, Aged, 80 and over, Antigens, Surface, Bone Marrow Cells, Cell Differentiation, Cells, Cultured, Fetal Blood, Humans, Osteogenesis, Immunophenotyping, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.